Foreign Corrupt Practices Act

HomeForeign Corrupt Practices Act

Search Whistleblower News

  • Foreign Corrupt Practices Act - Novartis Greece Bribery

Novartis Greece Bribery

By Joseph Orr|August 11th, 2020|

Kohn, Kohn and Colapinto and Athens-based Greek law firm of Pavlos K. Sarakis & Associates jointly represented Greek whistleblowers who proved that the multinational Swiss-based pharmaceutical company Novartis paid millions in bribes to illegally market drugs in violation of the Foreign Corrupt Practices Act.  Novartis was required to pay over $300 million in sanctions and fines to the U.S. Securities and Exchange Commission (SEC) and the U.S. Department of Justice (DOJ).